Dental Fear — Cognitive Behavioural Therapy and Dental Fear
Citation(s)
Armfield JM, Heaton LJ Management of fear and anxiety in the dental clinic: a review. Aust Dent J. 2013 Dec;58(4):390-407; quiz 531. doi: 10.1111/adj.12118. Review.
Armfield JM Development and psychometric evaluation of the Index of Dental Anxiety and Fear (IDAF-4C+). Psychol Assess. 2010 Jun;22(2):279-87. doi: 10.1037/a0018678.
Bernson JM, Elfström ML, Hakeberg M Adaptive coping strategies among adults with dental fear. Further development of a new version of the Dental Coping Strategy Questionnaire. Acta Odontol Scand. 2012 Sep;70(5):414-20. doi: 10.3109/00016357.2011.634830. Epub 2011 Nov 30.
Blevins CA, Weathers FW, Davis MT, Witte TK, Domino JL The Posttraumatic Stress Disorder Checklist for DSM-5 (PCL-5): Development and Initial Psychometric Evaluation. J Trauma Stress. 2015 Dec;28(6):489-98. doi: 10.1002/jts.22059. Epub 2015 Nov 25.
Davies JG, Wilson KI, Clements AL A joint approach to treating dental phobia: a re-evaluation of a collaboration between community dental services and specialist psychotherapy services ten years on. Br Dent J. 2011 Aug 26;211(4):159-62. doi: 10.1038/sj.bdj.2011.674. Erratum in: Br Dent J. 2011;211(6):262.
Goldberg LR The structure of phenotypic personality traits. Am Psychol. 1993 Jan;48(1):26-34. Review.
Gordon D, Heimberg RG, Tellez M, Ismail AI A critical review of approaches to the treatment of dental anxiety in adults. J Anxiety Disord. 2013 May;27(4):365-78. doi: 10.1016/j.janxdis.2013.04.002. Epub 2013 Apr 13. Review.
Hakeberg M, Berggren U Changes in sick leave among Swedish dental patients after treatment for dental fear. Community Dent Health. 1993 Mar;10(1):23-9.
Haugejorden O, Klock KS, Astrøm AN, Skaret E, Trovik TA Socio-economic inequality in the self-reported number of natural teeth among Norwegian adults--an analytical study. Community Dent Oral Epidemiol. 2008 Jun;36(3):269-78. doi: 10.1111/j.1600-0528.2007.00367.x.
Humphris GM, Morrison T, Lindsay SJ The Modified Dental Anxiety Scale: validation and United Kingdom norms. Community Dent Health. 1995 Sep;12(3):143-50.
Schuller AA, Willumsen T, Holst D Are there differences in oral health and oral health behavior between individuals with high and low dental fear? Community Dent Oral Epidemiol. 2003 Apr;31(2):116-21.
Strøm K, Rønneberg A, Skaare AB, Espelid I, Willumsen T Dentists' use of behavioural management techniques and their attitudes towards treating paediatric patients with dental anxiety. Eur Arch Paediatr Dent. 2015 Aug;16(4):349-55. doi: 10.1007/s40368-014-0169-1. Epub 2015 Mar 10.
Vika M, Skaret E, Raadal M, Ost LG, Kvale G One- vs. five-session treatment of intra-oral injection phobia: a randomized clinical study. Eur J Oral Sci. 2009 Jun;117(3):279-85. doi: 10.1111/j.1600-0722.2009.00628.x.
Willumsen T, Vassend O Effects of cognitive therapy, applied relaxation and nitrous oxide sedation. A five-year follow-up study of patients treated for dental fear. Acta Odontol Scand. 2003 Apr;61(2):93-9.
Zigmond AS, Snaith RP The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983 Jun;67(6):361-70.
The Effect of a Dentist Administered Cognitive Behavioural Therapy (D-CBT) in Adult Patients With Dental Fear
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
